ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
1.30
0.24 (22.64%)
At close: Jul 03, 2025, 3:59 PM
22.64% (1D)
| Bid | 1.32 |
| Market Cap | 59.49M |
| Revenue (ttm) | 24M |
| Net Income (ttm) | -46.12M |
| EPS (ttm) | -1.22 |
| PE Ratio (ttm) | -1.07 |
| Forward PE | -9.64 |
| Analyst | Buy |
| Ask | 1.33 |
| Volume | 2,641,911 |
| Avg. Volume (20D) | 1,871,327 |
| Open | 1.08 |
| Previous Close | 1.06 |
| Day's Range | 1.08 - 1.33 |
| 52-Week Range | 0.27 - 1.33 |
| Beta | 0.22 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on Jul 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
20 hours ago
+23.58%
ImmunoPrecise Antibodies shares are trading higher...
Unlock content with
Pro Subscription
1 week ago
+19.06%
ImmunoPrecise Antibodies shares are trading higher on possible continued strength after the company announced on Tuesday its AI-discovered dengue vaccine is safe and triggers an immune response.
